A randomized, open-label, multicenter study evaluating the efficacy of peginterferon alfa-2a versus interferon alfa-2a, in combination with ribavirin, in naïve and relapsed chronic hepatitis C patients.

Nevens F, Van Vlierberghe H, D’Heygere E, Delwaide J, Adler M, Henrion J, Lenaerts A, Hendlisz A, Michielsen P, Bastens B, Brenard R, Laureys A; BERNAR-1 Study Group. Acta Gastroenterol Belg. 2010 Apr-Jun;73(2):223-8.

Voir l’article

Retour aux publications